- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Utah Medical Products Inc (UTMD)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: UTMD (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit -24.43% | Avg. Invested days 35 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 187.75M USD | Price to earnings Ratio 15.25 | 1Y Target Price - |
Price to earnings Ratio 15.25 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.28 | 52 Weeks Range 50.98 - 75.79 | Updated Date 06/29/2025 |
52 Weeks Range 50.98 - 75.79 | Updated Date 06/29/2025 | ||
Dividends yield (FY) 2.11% | Basic EPS (TTM) 3.79 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 33% | Operating Margin (TTM) 35.71% |
Management Effectiveness
Return on Assets (TTM) 7.06% | Return on Equity (TTM) 10.59% |
Valuation
Trailing PE 15.25 | Forward PE - | Enterprise Value 104398199 | Price to Sales(TTM) 4.78 |
Enterprise Value 104398199 | Price to Sales(TTM) 4.78 | ||
Enterprise Value to Revenue 2.66 | Enterprise Value to EBITDA 6.82 | Shares Outstanding 3248210 | Shares Floating 2801744 |
Shares Outstanding 3248210 | Shares Floating 2801744 | ||
Percent Insiders 7.04 | Percent Institutions 70.75 |
Upturn AI SWOT
Utah Medical Products Inc

Company Overview
History and Background
Utah Medical Products, Inc. was founded in 1977. The company focuses on developing, manufacturing, and marketing medical devices. Over the years, it has expanded its product portfolio through internal development and strategic acquisitions, aiming to address specific clinical needs in areas like obstetrics, gynecology, and critical care.
Core Business Areas
- Obstetrics & Gynecology: This segment includes products for labor and delivery, such as fetal monitoring devices and ultrasound probes, as well as gynecological instruments for procedures like hysterectomies and minimally invasive surgery.
- Critical Care & Urology: This area encompasses devices for managing fluid and blood, including blood pressure monitoring systems and infusion pumps, as well as products for urological procedures.
- Other Medical Devices: This may include a variety of specialized medical devices catering to different healthcare needs.
Leadership and Structure
Utah Medical Products Inc. operates with a management team comprised of a CEO, CFO, and other key executives responsible for product development, sales, marketing, and operations. The company's structure is designed to facilitate innovation and efficient production of its medical devices.
Top Products and Market Share
Key Offerings
- Product Name 1: Fetal Monitoring Systems: These systems are used to monitor the heart rate of a fetus during pregnancy and labor. Competitors include Philips Healthcare, GE Healthcare, and Siemens Healthineers. Specific market share data for Utah Medical Products Inc. in this niche is not readily available but is a significant contributor. Annual revenue from this segment is a substantial portion of overall company revenue.
- Product Name 2: Gynecological Instruments: This includes a range of surgical instruments for procedures like hysteroscopy and endometrial ablation. Competitors vary depending on the specific instrument but can include companies like Karl Storz, Stryker, and Olympus. This segment contributes to the company's revenue stream and holds a notable position in its specialized market.
- Product Name 3: Blood Pressure Monitoring Systems: Devices used in critical care settings for continuous and accurate blood pressure monitoring. Competitors include Masimo, Medtronic, and Edwards Lifesciences. Utah Medical Products Inc. has a dedicated user base for these reliable systems.
Market Dynamics
Industry Overview
The medical device industry is characterized by continuous innovation, stringent regulatory requirements (FDA in the US), and a growing demand driven by an aging global population, increasing prevalence of chronic diseases, and advancements in healthcare technology. The market is competitive, with both large, established players and smaller, specialized companies.
Positioning
Utah Medical Products Inc. positions itself as a developer and manufacturer of specialized, high-quality medical devices. Its competitive advantages often lie in its focus on specific clinical niches, proprietary technologies, and established relationships with healthcare providers. The company aims to offer innovative solutions that improve patient outcomes and procedural efficiency.
Total Addressable Market (TAM)
The TAM for Utah Medical Products Inc.'s product categories (obstetrics, gynecology, critical care, urology) is substantial, running into billions of dollars globally. The company is positioned as a significant niche player within these broader markets, focusing on specific segments where it can leverage its expertise and product differentiation.
Upturn SWOT Analysis
Strengths
- Established reputation for quality and reliability in niche medical device markets.
- Proprietary technologies and innovative product development capabilities.
- Strong customer relationships with healthcare providers.
- Focus on specialized clinical areas allowing for deep market understanding.
Weaknesses
- Smaller company size compared to larger diversified medical device conglomerates, potentially limiting R&D budgets and global reach.
- Dependence on a limited number of key products.
- Vulnerability to regulatory changes and reimbursement policies.
Opportunities
- Expansion into emerging markets with growing healthcare needs.
- Development of next-generation technologies and smart medical devices.
- Strategic partnerships and collaborations to enhance market penetration.
- Acquisition of complementary technologies or smaller companies.
Threats
- Intense competition from larger, well-funded medical device companies.
- Rapid technological advancements by competitors.
- Economic downturns affecting healthcare spending.
- Increased regulatory scrutiny and compliance costs.
Competitors and Market Share
Key Competitors
- GE Healthcare (GE)
- Philips Healthcare (PHG)
- Siemens Healthineers AG (SHL.DE)
- Masimo Corporation (MASI)
- Medtronic plc (MDT)
Competitive Landscape
Utah Medical Products Inc. operates in a highly competitive landscape dominated by larger, well-capitalized players. Its advantages lie in its specialization, agility, and focus on specific unmet clinical needs, allowing it to carve out a defensible market share. However, it faces challenges in matching the R&D budgets and global reach of its larger rivals.
Growth Trajectory and Initiatives
Historical Growth: Historically, Utah Medical Products Inc. has demonstrated steady, albeit often incremental, growth driven by its specialized product lines and a consistent customer base. Growth has been fueled by both organic product development and strategic acquisitions.
Future Projections: Future growth is projected to be driven by continued innovation in its core segments, potential expansion into new geographic markets, and the adoption of its devices in evolving healthcare practices. Analyst estimates would provide specific growth percentage targets.
Recent Initiatives: Recent initiatives likely include the development and launch of new product iterations, investments in manufacturing capabilities, and efforts to enhance sales and distribution networks. The company may also be exploring strategic partnerships or further acquisitions.
Summary
Utah Medical Products Inc. is a niche medical device manufacturer with a strong history in obstetrics, gynecology, and critical care. Its strengths lie in product quality and specialized market focus, while it faces challenges from larger competitors and regulatory hurdles. Continued innovation and strategic market positioning are key to its sustained success and growth in the evolving healthcare landscape.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Investor Relations
- SEC Filings (10-K, 10-Q)
- Financial News Outlets
- Industry Research Reports
Disclaimers:
This analysis is based on publicly available information and should not be considered investment advice. Financial data and market share estimations are subject to change and may not be entirely precise. Investors should conduct their own due diligence before making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Utah Medical Products Inc
Exchange NASDAQ | Headquaters Midvale, UT, United States | ||
IPO Launch date 1999-03-08 | Chairman, CEO, President & Secretary Mr. Kevin L. Cornwell | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 155 | Website https://www.utahmed.com |
Full time employees 155 | Website https://www.utahmed.com | ||
Utah Medical Products, Inc. provides medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company also provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. The company serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

